Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cryo-EM-guided subtractive optimization of a novel VCP/p97 inhibitor.

IUCrJ·2026
Same author

Gold Nanoparticle Radiosensitization for High-Dose-Rate Brachytherapy: Differential Efficacy of PEG- and RGD-Functionalized Gold Nanoparticles Across 2-Dimensional, 3-Dimensional, and in vivo Prostate Cancer Models.

International journal of nanomedicine·2026
Same author

A novel liposomal formulation of irinotecan comprising a combination of copper complexation and a transmembrane pH gradient to significantly improve irinotecan encapsulation and retention.

International journal of pharmaceutics·2026
Same author

Influence of radiotherapy dose rate on gold nanoparticle-induced radiosensitization from high dose-rate brachytherapy and external beam therapy.

Medical physics·2026
Same author

Radiosensitization by Docetaxel Prodrug-Loaded Lipid Nanoparticles in Pancreatic Cancer Xenografts.

Nanomaterials (Basel, Switzerland)·2025
Same author

Comprehensive analysis of the tumor targeting efficiency of functionalized nanoparticles in an immunocompetent environment.

Scientific reports·2025

Related Experiment Video

Updated: Jun 22, 2025

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

10.9K

In Vitro and In Vivo Synergetic Radiotherapy with Gold Nanoparticles and Docetaxel for Pancreatic Cancer.

Abdulaziz Alhussan1, Nolan Jackson1, Norman Chow2

  • 1Department of Physics and Astronomy, University of Victoria, Victoria, BC V8P 5C2, Canada.

Pharmaceutics
|June 27, 2024
PubMed
Summary

This study shows that combining gold nanoparticles (GNPs) with docetaxel (DTX) and radiotherapy (RT) significantly enhances pancreatic cancer treatment. The triple therapy improved tumor reduction and survival rates in preclinical models.

Keywords:
docetaxelgold nanoparticlesin vivopancreatic cancerradiotherapy

More Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.0K
Preparation and Photoacoustic Analysis of Cellular Vehicles Containing Gold Nanorods
10:46

Preparation and Photoacoustic Analysis of Cellular Vehicles Containing Gold Nanorods

Published on: May 2, 2016

6.9K

Related Experiment Videos

Last Updated: Jun 22, 2025

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

10.9K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.0K
Preparation and Photoacoustic Analysis of Cellular Vehicles Containing Gold Nanorods
10:46

Preparation and Photoacoustic Analysis of Cellular Vehicles Containing Gold Nanorods

Published on: May 2, 2016

6.9K

Area of Science:

  • Oncology
  • Nanotechnology
  • Radiotherapy

Background:

  • Pancreatic cancer presents significant treatment challenges.
  • Conventional therapies often have limitations in efficacy and side effects.
  • Nanoparticles offer novel approaches to enhance cancer treatment.

Purpose of the Study:

  • To investigate the synergistic effects of gold nanoparticles (GNPs) and docetaxel (DTX) as radiosensitizers in pancreatic cancer.
  • To evaluate the efficacy of the combination therapy (GNPs/DTX/RT) in vitro and in vivo.

Main Methods:

  • Utilized a MIA PaCa-2 monoculture spheroid model for in vitro studies.
  • Employed NRG mice bearing MIA PaCa-2 tumors for in vivo studies.
  • Administered treatments including GNPs, DTX, and radiotherapy (RT) at specific doses and radiation levels.

Main Results:

  • The triple combination (DTX/RT/GNPs) significantly reduced spheroid size by 48% and increased DNA double-strand breaks (DSBs) by 45% in vitro.
  • In vivo, the (GNPs/RT/DTX) treatment resulted in a 20% reduction in tumor growth and improved median survival in mice.
  • Demonstrated a synergistic anticancer effect exceeding that of individual treatments.

Conclusions:

  • The combination of GNPs, DTX, and RT exhibits synergistic efficacy against pancreatic cancer.
  • This triple therapy holds potential for improving radiotherapy outcomes and potentially reducing adverse effects.
  • Further research into nanoparticle-enhanced radiotherapy for challenging cancers is warranted.